We surmised that drug inhibition of both Cdk4 (and thus indirectly, CAD) along with the next enzyme in the pyrimidine synthesis pathway, DHODH, would lead to pyrimidine starvation and thus effectively target HCC cell growth. Here, DHODH is linked to hepatocellular carcinoma.